Connor, Clark & Lunn Investment Management (CC&L)
RYTM icon

Connor, Clark & Lunn Investment Management (CC&L)’s Rhythm Pharmaceuticals RYTM Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$7.27M Buy
2025
Q1 		$2.68M Buy
2024
Q4 		$341K Buy
2024
Q3 		– Sell
2024
Q2 		$384K Sell
2024
Q1 		$419K Sell
2023
Q4 		$3.01M Sell
2023
Q3 		$3.02M Buy
2023
Q2 		$958K Buy
2022
Q3 		– Sell
2022
Q2 		$47K Buy